Peptide record

TPDB43899

Antiviral standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43899
Antiviral
Anti-infective peptides
AI4AVP Peptipedia
standard
No
A 30-aa standard-residue antiviral peptide sequence curated from AI4AVP and Peptipedia, with an available 3D structural model.
Sequence
TLKNRYYEPRDSYFQQYMLKGEYQYWFDLD
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C185H255N43O53S1
ACHIV
Y
3961.38
4.65
4
5
13
-1
2.81
-1.387
39.00
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
14440
3.65
12
Residue Composition
number
0
A
2
R
1
N
3
D
0
C
2
E
3
Q
1
G
0
H
0
I
3
L
2
K
1
M
2
F
1
P
1
S
1
T
1
W
6
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 1 D: 3 C: 0 E: 2 Q: 3 G: 1 H: 0 I: 0 L: 3 K: 2 M: 1 F: 2 P: 1 S: 1 T: 1 W: 1 Y: 6 V: 0
Chemical Descriptors
30 reviewed residue count
C185H255N43O53S1 sequence-only estimate (linear, free termini)
3961.38 sequence-only estimate (linear, free termini)
4.65 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
2.81 sequence-only estimate (linear, free termini)
-1.387 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA